(0.43%) 5 122.12 points
(0.30%) 38 353 points
(0.51%) 16 009 points
(-0.39%) $83.52
(2.13%) $1.964
(-0.10%) $2 344.90
(0.02%) $27.54
(2.79%) $947.85
(0.05%) $0.935
(-0.03%) $11.02
(-0.21%) $0.799
(1.89%) $93.61
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 0.00%
0.07% DKK 887.20
Live Chart Being Loaded With Signals
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease...
Stats | |
---|---|
Dzisiejszy wolumen | 648 231 |
Średni wolumen | 2.74M |
Kapitalizacja rynkowa | 3 992.63B |
EPS | DKK0 ( 2024-01-30 ) |
Następna data zysków | ( DKK5.38 ) 2024-05-01 |
Last Dividend | DKK0 ( N/A ) |
Next Dividend | DKK0 ( N/A ) |
P/E | 47.65 |
ATR14 | DKK0.488 (0.06%) |
Wolumen Korelacja
Novo Nordisk A/S Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Novo Nordisk A/S Korelacja - Waluta/Towar
Novo Nordisk A/S Finanse
Annual | 2023 |
Przychody: | DKK232.26B |
Zysk brutto: | DKK196.50B (84.60 %) |
EPS: | DKK18.67 |
FY | 2023 |
Przychody: | DKK232.26B |
Zysk brutto: | DKK196.50B (84.60 %) |
EPS: | DKK18.67 |
FY | 2022 |
Przychody: | DKK176.95B |
Zysk brutto: | DKK148.51B (83.92 %) |
EPS: | DKK24.51 |
FY | 2021 |
Przychody: | DKK140.80B |
Zysk brutto: | DKK117.14B (83.20 %) |
EPS: | DKK20.79 |
Financial Reports:
No articles found.
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej